Fennec Pharma Competitors and Similar CompaniesClear all
Fennec Pharma's competitors and similar companies include Urogen Pharma, LadRx, Rasna Therapeutics and Repertoire Immune Medicines.
 Fennec Pharma Fennec Pharmaceuticals is a biotechnology company focused on the development of Sodium Thiosulfate for the prevention of ototoxicity from cisplatin in pediatric patients. |  LadRx LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer. |  Rasna Therapeutics Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia. |  Repertoire Immune Medicines Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases. | ||
Founding Date | Founding Date 1996 | Founding Date 2004 | Founding Date 1985 | Founding Date 2013 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations US HQ | Locations New York, US HQ Tel Aviv Yafo, IL Princeton, US | Locations Los Angeles, US HQ | Locations New York, US HQ Greater London, GB Doylestown, US | Locations Cambridge, US HQ Schlieren, CH Cambridge, US |
Employees | Employees 433% increase | Employees 194362% increase | Employees 385% decrease | Employees N/A | Employees 887% increase |
Valuation ($) | Valuation ($) 129.4 m | Valuation ($) 515.9 m | Valuation ($) 901.1 k | Valuation ($) 3.1 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $44.6m (FY, 2025) | Revenue (est.) $109.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($9.7m) (FY, 2025) | Net income ($153.5m) (FY, 2025) | Net income ($1.6m) (FY, 2024) | Net income ($4.4m) (FY, 2023) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Urogen Pharma
HQ
New York, US
Employees
194
UroGen Pharma is a clinical-stage biopharmaceutical company.
View companyLadRx
HQ
Los Angeles, US
Employees
3
LadRx Corporation (formerly known as CytRx Corporation) is a biopharmaceutical company focused on discovering, developing and commercializing new therapeutics to treat patients with cancer.
View companyRasna Therapeutics
HQ
New York, US
Rasna Therapeutics focusses on development therapeutics to address the high unmet need that exists for AML and other forms of leukemia.
View companyRepertoire Immune Medicines
HQ
Cambridge, US
Employees
88↑ 7% increase
Repertoire Immune Medicines is a biotechnology company tapping the curative powers of the immune system to prevent, treat, or cure cancer, autoimmune conditions, and infectious diseases.
View company